SINT SINTX TECHNOLOGIES INC.

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Announces Stock Repurchase Program

Salt Lake City, UT , Nov. 18, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, today announced that its Board of Directors has authorized a stock repurchase program to buy back up to $500,000 of the company’s outstanding common stock over the next several quarters which equates to about 20% of total outstanding shares. The repurchases will be conducted based on market conditions and other factors, reflecting SINTX’s confidence in its strategic direction and commitment to enhancing shareholder value.

Strategic Rationale

This initiative aligns with SINTX’s strategic focus on optimizing its capital structure and delivering long-term value to shareholders. By repurchasing shares, the company aims to reduce the number of outstanding shares, thereby increasing the ownership stake of remaining shareholders and enhancing earnings per share. Similar to actions taken by other industry leaders, SINTX believes that a stock repurchase program is an effective way to return capital to shareholders.

Management Commentary

“We believe that the current market undervalues SINTX’s potential,” said Eric Olson, CEO of SINTX Technologies. “This repurchase program underscores our confidence in the company’s strategic initiatives and our commitment to delivering value to our shareholders. By leveraging our strong balance sheet, we are taking a proactive approach to capital allocation, similar to other companies in our industry that have successfully implemented share repurchase programs.”

Program Details

The stock repurchase program will be managed by Maxim Group, LLC, a recognized leader in investment banking and asset management. The repurchase program does not obligate the Company to acquire any particular amount of common shares, and the repurchase program may be suspended or discontinued at any time at the Company’s discretion. The timing and amount of any share repurchases under the share repurchase program will be determined by SINTX’s management at its discretion based on ongoing assessments of the capital needs of the business, the market price of the Company’s common stock, corporate and regulatory requirements, and general market conditions. Share repurchases under the program may be made through a variety of methods, which may include open market purchases, in block trades, accelerated share repurchase transactions, exchange transactions, the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or any combination of such methods.

For more information, please visit

About SINTX Technologies, Inc.

SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. The Company has manufacturing and R&D facilities in Utah and Maryland. For more information on SINTX Technologies or its materials platform, visit .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”) that are subject to a number of risks and uncertainties. Forward-looking statements can be identified by words such as: "anticipate," "believe," "project," "estimate," "expect," "strategy,” "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding advancement of ceramic technologies and exploring new avenues for growth and innovation, and the potential to pursue growth opportunities and explore strategic opportunities.

Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, difficulty in commercializing ceramic technologies and development of new product opportunities. A discussion of other risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the SEC on March 27, 2024, and in SINTX’s other filings with the SEC. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report, except as required by law.

Business and Media Inquiries for SINTX:

SINTX Technologies

801.839.3502



EN
18/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SINTX TECHNOLOGIES INC.

 PRESS RELEASE

SINTX Technologies to Participate in Noble Capital Markets’ Emerging G...

SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announced that its management team will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference, to be held February 4–5, 2026. The Company’s participation comes at an important stage in its evolution, following a period o...

 PRESS RELEASE

SINTX Technologies to Participate in Sidoti & Company Investor Confere...

SINTX Technologies to Participate in Sidoti & Company Investor Conference SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ETWebcast: To schedule a one-on-one meeting with SINTX Technologies’ management team, please email KCSA Strategic ...

 PRESS RELEASE

SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstell...

SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate Ein Meilenstein, der die sofortige Produktion von maßgefertigten SiN/PEEK-Implantaten ermöglicht SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) („SINTX” oder das „Unternehmen”), ein Unternehmen für innovative Keramik und Biomaterialien, gab heute die Unterzeichnung eines Liefervertrags mit Evonik Corporation („EVONIK”), einem weltweit führenden Anbieter von Ho...

 PRESS RELEASE

SINTX Technologies 与 EVONIK 签署供应协议,将生产用于人工智能辅助 3D 打印患者定制植入物的氮化硅-PEEK 复...

SINTX Technologies 与 EVONIK 签署供应协议,将生产用于人工智能辅助 3D 打印患者定制植入物的氮化硅-PEEK 复合材料 该里程碑使 SiN/PEEK 定制器械能够立即投产 犹他州盐湖城, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先进陶瓷和生物材料公司 SINTX Technologies, Inc. (NASDAQ: SINT) (简称“SINTX”或“公司”)今天宣布,已与高性能聚合物领域的全球领导企业 Evonik Corporation(简称“EVONIK”)签署供应协议,由 EVONIK 生产 SINTX 的专有氮化硅-PEEK 复合材料(SiN/PEEK,美国专利号 10806831)。该材料专为人工智能辅助的患者定制植入物增材制造而设计,并将使用 SINTX 位于美国的现有生产设施完成制造。 根据协议,EVONIK 将利用其商业规模生产能力,按照 SINTX 的规格生产 SiN/PEEK 复合材料,使 SINTX 能够立即开始制造人工智能设计 3D 打印患者定制植入物。 SINTX 公司已经收到医生提出的请求,希望该公司能为脊柱肿瘤切除术后的骨科和神经外科肿瘤患者提供用于人道主义用途的椎体置换 (VBR) 植入物。 此外,该公司计划使用 SiN/PEEK 复合材料支持患者匹配型植入物及采用传统减材制...

 PRESS RELEASE

SINTX Technologies 與 EVONIK 簽署供應協議,生產用於人工智能輔助 3D 打印患者專屬植入物的氮化矽–PEEK 複合...

SINTX Technologies 與 EVONIK 簽署供應協議,生產用於人工智能輔助 3D 打印患者專屬植入物的氮化矽–PEEK 複合材料 此里程碑讓 SiN/PEEK 定制儀器得以即時投產 猶他州鹽湖城, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先進陶瓷與生物材料公司 SINTX Technologies, Inc. (NASDAQ: SINT) (「SINTX」或「該公司」) 今日宣佈,已與高性能聚合物全球領導者 Evonik Corporation (「EVONIK」) 簽署供應協議,生產該公司專利的氮化矽–PEEK(即聚醚醚酮)複合材料 (SiN/PEEK) (美國專利編號:10,806,831),此材料專為人工智能 (AI) 輔助增材製造患者專屬植入物而設計,將運用 SINTX 美國生產基地現有設備來生產。 根據協議,EVONIK 將發揮達到商業規模的生產能力,按照 SINTX 規格生產 SiN/PEEK 複合材料,使該公司能夠立即開始製造由 AI 設計、3D 打印的患者專屬植入物。SINTX 已收到醫生請求,為脊椎腫瘤切除後的骨科及神經外科腫瘤患者,提供人道使用的椎體替換(VBR)植入式儀器。此外,該公司打算運用 SiN/PEEK 複合材料,支援患者匹配及傳統減材製造植入式儀器的監管批准。 SINTX 主席、董事長暨行...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch